Madhav R. Seshadri

Dr. Madhav R. Seshadri is a hematologist-oncologist who specializes in caring for patients with blood cancers, with a particular focus on Hodgkin's lymphoma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia. He has expertise in advanced cancer treatments, such as stem cell transplants, targeted therapies (using substances that can identify cancer cells and kill them or hinder their ability to spread) and immunotherapies, including CAR T-cell therapy (in which the patient's own T-cells are altered in a lab to make them destroy cancer cells, then returned to the patient by infusion).

In his research, Seshadri focuses on developing new combinations of immunotherapy and targeted therapies to improve outcomes for patients with lymphoma. He is a principal investigator of multiple ongoing clinical trials (studies that use human volunteers to evaluate promising treatments) and has received several awards for his work.

Seshadri earned his medical degree at Emory University. He completed a residency in internal medicine and a fellowship in hematology and oncology at Weill Cornell Medicine.

In addition to his work at UCSF, Seshadri currently serves on the National Comprehensive Cancer Network's guidelines panel for chronic lymphocytic leukemia.